| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Matrix metalloproteinase-9|MMP-9|92 kDa gelatinase|92 kDa type IV collagenase|Gelatinase B|GELB|MMP9|CLG4B |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human MMP-9 (Matrix Metalloproteinase 9) is a molecular target commonly studied in cancer, cardiovascular, and metabolism research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of MMP-9 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of MMP-9 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
MMP-9 (Matrix Metalloproteinase 9) may also be referenced as Matrix metalloproteinase-9, MMP-9, and 92 kDa gelatinase in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how MMP-9 relates to tumor microenvironment biology, cell proliferation and apoptosis, metastasis and invasion pathways, and angiogenesis and immune-oncology mechanisms in cancer, cardiovascular, and metabolism research.
- Interpreting shifts in MMP-9 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
MMP-9 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with cancer, cardiovascular, and metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Sporadic cell death in macroscale 3D tumor grafts with high drug resistance by activating cell-ECM interactions
IF: 9.954 Journal: Biofabrication Cited Date: 2021-09-16
Gel-to-Coacervate Transition in Peptide/HA Complexes for MMP-9-Activated Penetration into Tumor Spheroids
IF: 8.5 Journal: ACS Applied Materials & Interfaces Author: State Key Laboratory of Metal Matrix Composites, School of Material Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. Cited Date: 2025-03-21
Decellularized plant-derived vasculature-on-a-chip interacting with breast cancer spheroids to evaluate a dual-drug therapy
IF: 8.3 Journal: Applied Materials Today Author: Department of Bioengineering, Faculty of Engineering, Ege University, 35100 Izmir, Turkey Cited Date: 2023-12-22
RGD and (?)-epigallocatechin-3-gallate modification enhanced biostability, bioactive and biofunctionality of acellular porcine cornea stroma crosslinked with oxidized dextran
IF: 7.6 Journal: Materials and Design Author: NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, & Institute of Regulatory Science for Medical Device, & National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China Cited Date: 2024-07-19
Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
IF: 5.7 Journal: Frontiers in Cellular and Infection Microbiology Author: Department of Neurology, the Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China Cited Date: 2023-07-28
SERPINA3: A novel inflammatory biomarker associated with cerebral small vessel disease burden in ischemic stroke
IF: 5.5 Journal: CNS Neuroscience & Therapeutics Author: Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China Cited Date: 2023-09-28
Is Fluoride Blameless?—The Influence of Fluorine Compounds on the Invasiveness of the Human Glioma-like Cell Line U-87
IF: 4.9 Journal: International Journal of Molecular Sciences Author: Department of Medical Chemistry, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland. Cited Date: 2024-12-20
MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-α and VEGF in Patients with Different Phenotypes of Coronary Artery Disease
IF: 4.9 Journal: International Journal of Molecular Sciences Author: Department of Hospital Therapy No 1, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119048 Moscow, Russia. Cited Date: 2024-12-20